EIF2A and glioblastoma: Upstream of UPR signaling, overexpressed CREB3 in GBM patients and U251 cells promotes PERK/eIF2α/ATF4 activation in vitro and in vivo, leading to BAX overexpression and caspase-3 cleavage [153].